Member Info for PlantPower

I also see 87-94 on L2 ADVFN.

Strange old game - maybe we need a 6th MM ;0)

....with a POC prototype testing pre-entry.

Party round Bud’s pad once they land...

Just over 2 weeks ago we had a seismic announcement in terms of laying springboard.

I don’t personally won’t non-material updates.

Expect team are busy building strategic partnerships to maximise & capitalise on approvals once landed.

DB has made strategic decision to focus on a few large pharma / gov (?) partnerships (i expect) rather than selling small fry volume to multiple customers. Large, long term & sustainable contracts to maximise our capacity output, which will deliver the most shareholder value.

Understand frustration to a degree, but we’ve not even started the race yet - patience is the key.

Alternatively, we can all vote with our cash.

PP

Looks like we’re going to see a miracle - look forward to it ;0)

PP

https://www.cnbc.com/amp/2020/08/20/coronavirus-germany-spain-record-highest-daily-cases-since-april.html?__source=sharebar%7Ctwitter&par=sharebar&__twitter_impression=true

....notice it’s bounced back after heavy losses post FED raising recovery concerns.

US & Asia stocks fell and oil dipped from 5-month high.

To point earlier, expect wider economy to be hit again and would expect Covid stocks to be back in play for any growth plays as we head out of summer.

PP

Ah, agree @Dave77 - expect correction in next few months for wider markets. Extremely surprised with some of the all time highs consistently backdrop.

Although would think Covid testing stocks would join (relatively) safe haven list...

PP

I think BC deal reduced probability of black swan event, but whilst so much hinges on external reg approvals, agreed, this always remains a risk (albeit not just isolated to GDR).

Uncertain on II seller, Calculus (8.99% at last update) - per ‘results’ section they were happy to promote ‘Genedrive (May 2020) 2.1x return’ but that was selling circa 140+, so would they be comfortable with smaller returns (presuming chunk of shares from placement - maybe they bought earlier, haven’t checked back yet).

Other option is Spreadex - as impatience wears thin maybe those who took long positions expecting approvals are retreating.

Also agree / believe there is a II buyer on play, on smaller scale than recent II seller.

https://www.calculuscapital.com/what-we-do/

At least we must now be closer to the end game vs 3 months ago.....news should be soon, we have a relatively firm date even if it’s just the BC update, but expect approvals will arrive ahead of time.

PP

100k vol delayed sells from yesterday (reason for SP plummet) just printed.

PP

....nice flurry finish, good to see strong support sub 90 in the face of strong downward pressure, appears new level of resistance which is good.

Still convinced seller in play - 200k vol+ of round sells....nicely absorbed though.

PP

Add another 2x20k vol & 2x5k vol.....something going on.

That’s 130k vol from just round 20/5k’s between 830-930 this morning.

Mmmmm

Come on @ThePunter, we all know it’s ‘toot toot‘....

PP

Hahahehehoho - worth a watch:

http://www.genedriveplc.com/company-reports/InvestorPresentationJune2020.pdf

....the new bell weather, up we tick again...

Always love a soggy biscuit in the morning

Round sells being pumped out - 8 x 5k vol + 2 x 20k vol.

PP

False dawns are v.frustrating - but concur with drlong, there should be so much to announce once FDA lands.

DB and team will be lining up dominoes to be toppled once FDA drops - excruciating as it is right now.

PP

@philjpo - appears 2 antibody & 1 molecular test approved.

Not saying it’s ours - but can you view the molecular approved test?

Bottom of page shows those approved - 18th not on yet:

https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/vitro-diagnostics-euas